Препараты Анемия

China Formally Arrests Japanese Employee of Dru...

Astellas Pharma Joins Record Bond Sales by Japa...

Astellas gets FDA priority review for gastric c...

Astellas Pharma Inc. (4503N.MX) stock price, ne...

FDA Grants Full Approval for Astellas Pharma's ...

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Pharmaceutical Technology

Атлас лекарственных растений - YouTube

Astellas Pharma: A Contrarian Investment (OTCMK...

Главная | Astellas Pharma Russia

FDA Approves Astellas’ Non-hormonal Menopause T...

Astellas Pharma to acquire Propella Therapeutic...

Home | Astellas Pharma Canada, Inc.

Astellas Sues Over New Myrbetriq Patent to Reca...

Astellas, University of Tokyo extend partnershi...

Astellas Home page | Astellas Pharma Inc.

FDA blocks Astellas’ Claudin cancer drug over m...

Asia Business Daily on Twitter: "Astellas Pharm...

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Japan's Astellas sees cancer drug fueling 29% p...

Главная | Astellas Pharma Russia

Astellas Pharma Projects :: Photos, videos, log...

Astellas Home page | Astellas Pharma Inc.

Astellas Pharma - Global Web Site on Behance

Astellas Offloads 5 Legacy Products to Germany’...

Astellas licenses 4DMT’s AAV vector for ophthal...

US FDA approves Astellas Pharma pill for menopa...

Astellas Pharma

Astellas' Prostate Cancer Drug Available In Jap...

Astellas Pharma EMEA celebrates its 10th annive...

About | Astellas Pharma Ltd

Astellas

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas introduces sustainable community initi...

Astellas Pharmaceuticals Establishes Open Innov...